Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences
Intercept Pharmaceuticals (NASDAQ: ICPT) and Gilead Sciences (NASDAQ: GILD) don't compete against each other at this point, but that just might change in the not-too-distant future.
In the meantime, Intercept and Gilead sort of battle each other in another way by fighting for investors' money. Which of these two biotech stocks is the better pick for long-term investors? Here's how Intercept and Gilead stack up against each other.
Image source: Getty Images.
Source Fool.com
